Soluble PD-1 and SPD-L2 unaffected by adalimumab treatment in early RA and associated with presence of anti-CCP and IGM-RF

S.R. Greisen, K. Steengaard-Pedersen, Merete Lund Hetland, Kim Hørslev-Petersen, B.W. Deleuran

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Issue numberSuppl. 3
Pages (from-to)803
Number of pages1
Publication statusPublished - 2013

Cite this